Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126975481 | 12697548 | 1 | I | 20160404 | 20160523 | 20160830 | 20160830 | PER | US-MYLANLABS-2016M1021541 | MYLAN | 50.91 | YR | F | Y | 139.23000 | KG | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126975481 | 12697548 | 1 | PS | ESOMEPRAZOLE MAGNESIUM D/R | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, QD IN THE MORNING | 520 | MG | Y | U | 3039443 | 78936 | 20 | MG | CAPSULE | QD | |
| 126975481 | 12697548 | 2 | SS | ESOMEPRAZOLE MAGNESIUM D/R | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | U | 78936 | CAPSULE | |||||||||
| 126975481 | 12697548 | 3 | C | Triamterene and Hydrochlorothiazide Capsules, USP | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | UNK | 0 | CAPSULE | ||||||||||
| 126975481 | 12697548 | 4 | C | PERCOCET /00446701/ | ACETAMINOPHENOXYCODONE HYDROCHLORIDEOXYCODONE TEREPHTHALATE | 1 | UNK | 0 | |||||||||||
| 126975481 | 12697548 | 5 | C | FLONASE /00908302/ | MOMETASONE FUROATE | 1 | UNK | 0 | |||||||||||
| 126975481 | 12697548 | 6 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | UNK | 0 | |||||||||||
| 126975481 | 12697548 | 7 | C | Lorazepam Tablets, USP | LORAZEPAM | 1 | UNK | 0 | TABLET | ||||||||||
| 126975481 | 12697548 | 8 | C | IRON /00023503/ | IRON | 1 | UNK | 0 | LIQUID | ||||||||||
| 126975481 | 12697548 | 9 | C | VITAMINS NOS | VITAMINS | 1 | UNK | 0 | |||||||||||
| 126975481 | 12697548 | 10 | C | CALCIUM | CALCIUM | 1 | UNK | 0 | |||||||||||
| 126975481 | 12697548 | 11 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126975481 | 12697548 | 1 | Gastrooesophageal reflux disease |
| 126975481 | 12697548 | 3 | Hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126975481 | 12697548 | Asthenia | |
| 126975481 | 12697548 | Contusion | |
| 126975481 | 12697548 | Dizziness | |
| 126975481 | 12697548 | Dyspepsia | |
| 126975481 | 12697548 | Headache | |
| 126975481 | 12697548 | Menstrual disorder | |
| 126975481 | 12697548 | Nasopharyngitis | |
| 126975481 | 12697548 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126975481 | 12697548 | 1 | 20160310 | 20160521 | 0 |